Tempus AI, Inc.TEMEarnings & Financial Report
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
TEM Q3 2025 Key Financial Metrics
Revenue
$334.2M
Gross Profit
N/A
Operating Profit
$-61.0M
Net Profit
$-80.0M
Gross Margin
N/A
Operating Margin
-18.3%
Net Margin
-23.9%
YoY Growth
84.7%
EPS
$-0.46
Financial Flow
Tempus AI, Inc. Q3 2025 Financial Summary
Tempus AI, Inc. reported revenue of $334.2M for Q3 2025, with a net profit of $-80.0M (-23.9% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $334.2M |
|---|---|
| Net Profit | $-80.0M |
| Gross Margin | N/A |
| Operating Margin | -18.3% |
| Report Period | Q3 2025 |
Tempus AI, Inc. Annual Revenue by Year
Tempus AI, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $693.4M).
| Year | Annual Revenue |
|---|---|
| 2024 | $693.4M |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136.1M | $145.8M | $166.0M | $180.9M | $200.7M | $255.7M | $314.6M | $334.2M |
| YoY Growth | N/A | N/A | 25.3% | 33.0% | N/A | 75.4% | 89.6% | 84.7% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | N/A | N/A | $864.6M | $971.7M | $926.1M | $1.54B | $1.63B | $2.28B |
| Liabilities | N/A | N/A | $766.4M | $918.0M | $869.8M | $1.22B | $1.32B | $1.77B |
| Equity | $-1.32B | $-1.47B | $98.3M | $53.7M | $56.3M | $326.2M | $309.6M | $507.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-101.4M | $-97.1M | $48.7M | $-105.6M | $44.2M | $-119.8M |